Home Supplements How We Rate Blog
Vitamin B3 / Nicotinic Acid

Niacin

Research reviewed: 2025-2026

Niacin (Vitamin B3 / Nicotinic Acid) is a dietary supplement with 14 published peer-reviewed studies involving 2,949 participants, researched for Cholesterol Management, Cardiovascular Health, Skin Health and 6 more areas.

14
Studies
2,949
Participants
1986–2026
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Cholesterol Management

Moderate
3 studies 1 of 3 positive 8,683 participants 2 human

Cardiovascular Health

Moderate
2 studies 0 of 2 positive 1,281 participants

Skin Health

Moderate
1 study 1 of 1 positive 50 participants

Energy Metabolism

Moderate
3 studies 1 of 3 positive 42 participants 1 human

Sleep Quality

Moderate
1 study 0 of 1 positive 0 participants

Liver Health

Moderate
1 study 0 of 1 positive 2,594 participants

Heart Health

Moderate
1 study 0 of 1 positive 0 participants

Antioxidant

Weak
1 study 0 of 1 positive 0 participants

Pain Relief

Moderate
1 study 0 of 1 positive 355 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

5/14
Randomised
3/14
Double-Blind
3/14
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2011)
3,414
Study 2 (2009)
5,000
Study 3 (2004)
269
Study 1 (1990)
162
Study 2 (1986)
1,119
Study 1 (2005)
50
Study 1 (2018)
0
Study 2 (2020)
42

Research Timeline

When the studies were published

1
1986
1
1990
1
2004
1
2005
1
2009
1
2011
1
2015
1
2018
1
2020
3
2025
2
2026

All Studies

Detailed breakdown of each trial. Click to expand.

Cholesterol Management

1

To evaluate the effect of extended-release niacin on HDL cholesterol and cardiovascular events in statin-treated patients.

2011 3,414 participants 3 years 2,000 mg/day extended-release niacin
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate the effect of extended-release niacin on HDL cholesterol and cardiovascular events in statin-treated patients.

Dose

2,000 mg/day extended-release niacin

Participants

3,414 adults with established cardiovascular disease on statin therapy

Duration

3 years

Results

Niacin significantly raised HDL-C by 25% and lowered triglycerides by 28.6%. However, no incremental cardiovascular benefit was observed beyond statin therapy alone in this population.

How They Measured It

Lipid panels, major adverse cardiovascular events

Read full study
2

To evaluate niacin's effects on lipid profiles across multiple randomised trials.

2009 5,000 participants Various 1,000-3,000 mg/day niacin
Review/Other Mixed

Study Type

Meta-analysis

Purpose

To evaluate niacin's effects on lipid profiles across multiple randomised trials.

Dose

1,000-3,000 mg/day niacin

Participants

Over 5,000 patients across included trials

Duration

Various

Results

Niacin consistently raised HDL-C (average +16-23%) and lowered LDL-C (-5-25%) and triglycerides (-10-30%) across studies. The lipid-modifying effect is well established.

How They Measured It

Pooled changes in HDL, LDL, total cholesterol, triglycerides

Read full study
3

To compare immediate-release versus extended-release niacin on lipid outcomes and tolerability.

2004 269 participants 12 weeks 1,500 mg/day immediate-release or extended-release niacin
Human Study RCT Positive

Study Type

Randomised, controlled trial

Purpose

To compare immediate-release versus extended-release niacin on lipid outcomes and tolerability.

Dose

1,500 mg/day immediate-release or extended-release niacin

Participants

269 patients with dyslipidaemia

Duration

12 weeks

Results

Both formulations improved lipid profiles similarly. Extended-release niacin caused significantly less flushing, but immediate-release had lower risk of elevated liver enzymes.

How They Measured It

Lipid panels, flushing incidence, liver function tests

Read full study

Cardiovascular Health

1

To examine the effect of niacin on coronary artery disease progression.

1990 162 participants 4 years 3,000 mg/day niacin with colestipol
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To examine the effect of niacin on coronary artery disease progression.

Dose

3,000 mg/day niacin with colestipol

Participants

162 men with coronary artery disease

Duration

4 years

Results

Niacin/colestipol combination significantly slowed coronary atherosclerosis progression and was associated with regression of lesions in a subset of patients. HDL-C increased by 37%.

How They Measured It

Coronary angiography, HDL-C levels

Read full study
2

To assess the long-term mortality benefit of niacin therapy.

1986 1,119 participants 15 years (post-trial follow-up) 3,000 mg/day niacin
Human Study Mixed

Study Type

Prospective cohort study

Purpose

To assess the long-term mortality benefit of niacin therapy.

Dose

3,000 mg/day niacin

Participants

1,119 men (from Coronary Drug Project)

Duration

15 years (post-trial follow-up)

Results

Long-term follow-up of the Coronary Drug Project showed niacin-treated patients had 11% lower all-cause mortality compared to placebo at 15 years, suggesting a lasting cardiovascular mortality benefit.

How They Measured It

All-cause mortality, cardiovascular mortality at 15-year follow-up

Read full study

Skin Health

1

To evaluate topical niacinamide effects on skin appearance (note: closely related nicotinamide form).

2005 50 participants 12 weeks 5% topical niacin/niacinamide cream
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate topical niacinamide effects on skin appearance (note: closely related nicotinamide form).

Dose

5% topical niacin/niacinamide cream

Participants

50 women with photoaged skin

Duration

12 weeks

Results

Niacin/niacinamide formulation significantly improved skin texture, reduced hyperpigmentation, and improved barrier function compared to vehicle control.

How They Measured It

Skin barrier function, sebum production, blotchiness scores

Read full study

Energy Metabolism

1

To describe the role of niacin (NAD+) in cellular energy production.

2018 ? participants N/A N/A
Review/Other Mixed

Study Type

Review

Purpose

To describe the role of niacin (NAD+) in cellular energy production.

Dose

N/A

Participants

N/A

Duration

N/A

Results

Niacin is an essential precursor to NAD+ and NADP+, coenzymes critical for over 400 enzymatic reactions including glycolysis, the TCA cycle, and oxidative phosphorylation. Adequate niacin is essential for cellular energy production.

How They Measured It

Literature review of mechanistic studies

Read full study
2

To evaluate niacin supplementation on NAD+ levels and mitochondrial function in older adults.

2020 42 participants 10 weeks 250 mg/day nicotinic acid
Human Study RCT Positive

Study Type

Randomised, controlled trial

Purpose

To evaluate niacin supplementation on NAD+ levels and mitochondrial function in older adults.

Dose

250 mg/day nicotinic acid

Participants

42 older adults

Duration

10 weeks

Results

Niacin supplementation significantly increased whole-blood NAD+ and skeletal muscle NAD+ levels. Improvements in mitochondrial respiration capacity were observed, supporting niacin's role in energy metabolism.

How They Measured It

Blood NAD+ levels, skeletal muscle NAD+ content, mitochondrial bioenergetics

Read full study
3

To examine how niacin deficiency affects oxidative phosphorylation in muscle tissue.

2015 ? participants 8 weeks Niacin-deficient diet
Animal Study Positive

Study Type

Animal study

Purpose

To examine how niacin deficiency affects oxidative phosphorylation in muscle tissue.

Dose

Niacin-deficient diet

Participants

Sprague-Dawley rats

Duration

8 weeks

Results

Niacin-deficient animals showed significantly impaired mitochondrial complex I activity and reduced NAD+/NADH ratios in muscle tissue. Repletion with niacin fully restored mitochondrial function.

How They Measured It

Mitochondrial enzyme complex activity, NAD+/NADH ratio in muscle tissue

Read full study

Sleep Quality

4

Isolating the effects of carbohydrate and lipid availability on exercise-induced skeletal muscle signalling in males.

2026 ? participants 6 days See study
Human Study Mixed

Study Type

Clinical Trial

Purpose

Isolating the effects of carbohydrate and lipid availability on exercise-induced skeletal muscle signalling in males.

Dose

See study

Participants

Not specified

Duration

6 days

Results

Study results available at linked source.

How They Measured It

PubMed PMID: 41243363. J Physiol

Read full study

Liver Health

5

Dietary Intake and Nutrient Adequacies among Women of Reproductive Age in Northern Tanzania: A Cross-Sectional Study.

2026 2594 participants Not specified See study
Human Study Mixed

Study Type

RCT

Purpose

Dietary Intake and Nutrient Adequacies among Women of Reproductive Age in Northern Tanzania: A Cross-Sectional Study.

Dose

See study

Participants

2594 participants

Duration

Not specified

Results

CONCLUSIONS: Substantial nutrient inadequacies exist among WRA in rural Northern Tanzania due to high cereal intake and low intake of F&V and ASF.

How They Measured It

PubMed PMID: 41238119. J Nutr

Read full study

Heart Health

6

Targeting cardiovascular and metabolic risk modification in end stage renal disease (ESRD): a randomized controlled clinical trial on niacin's effects

2025 ? participants 3 months See study
Human Study Positive

Study Type

RCT

Purpose

Targeting cardiovascular and metabolic risk modification in end stage renal disease (ESRD): a randomized controlled clinical trial on niacin's effects

Dose

See study

Participants

Not specified

Duration

3 months

Results

CONCLUSION: Niacin (500 mg/day) offers significant cardiovascular and metabolic benefits for hemodialysis patients, supporting its role as an adjunctive therapy in managing ESRD-associated risks.

How They Measured It

PubMed PMID: 41140700. Front Med (Lausanne)

Read full study

Antioxidant

7

Antioxidant Treatment and the Chance to Conceive in Men Seeking Fertility Care: The SUMMER Randomized Clinical Trial.

2025 ? participants 6 months See study
Human Study Mixed

Study Type

RCT

Purpose

Antioxidant Treatment and the Chance to Conceive in Men Seeking Fertility Care: The SUMMER Randomized Clinical Trial.

Dose

See study

Participants

Not specified

Duration

6 months

Results

CONCLUSIONS AND RELEVANCE: This randomized clinical trial found that ongoing pregnancy rates did not improve with the antioxidant supplement compared with a placebo.

How They Measured It

PubMed PMID: 40996763. JAMA Netw Open

Read full study

Pain Relief

8

Impact of sustainable diets on micronutrient intakes and status: outcomes of the MyPlanetDiet randomized controlled trial.

2025 355 participants 3 weeks See study
Human Study Mixed

Study Type

RCT

Purpose

Impact of sustainable diets on micronutrient intakes and status: outcomes of the MyPlanetDiet randomized controlled trial.

Dose

See study

Participants

355 participants

Duration

3 weeks

Results

CONCLUSIONS: A diet based on sustainable dietary principles lowered dietary GHGE and several MNs, despite the provision of daily servings of dairy, 3 weekly servings of animal protein, and 2 serving.

How They Measured It

PubMed PMID: 40930463. Am J Clin Nutr

Read full study

Frequently Asked Questions

Common questions about Niacin research

What does the research say about Niacin?

There are currently 14 peer-reviewed studies on Niacin (Vitamin B3 / Nicotinic Acid), involving 2,949 total participants. Research covers Cholesterol management, Cardiovascular health, Skin health and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Niacin?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (11 human studies, 1 animal study), and reported outcomes.

What health goals has Niacin been studied for?

Niacin has been researched for: Cholesterol management, Cardiovascular health, Skin health, Energy metabolism. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Niacin based on human trials?

Yes, 11 out of 14 studies are human trials. The remaining 1 is an animal study. Human trials carry more weight in our evidence scoring system.